2025 Annual Meeting | C118 - Basic Science: Neuropathology
Program Materials Program Evaluations
01:00 PM - 01:05 PM PDT | Introduction |
Introduction
Ashley Holloman, MD |
01:05 PM - 01:35 PM PDT | Speaker |
Tumors
Hsiang-Chih Lu, MD, PhD |
01:35 PM - 02:05 PM PDT | Speaker |
Infectious Disease
Hsiang-Chih Lu, MD, PhD |
02:05 PM - 02:35 PM PDT | Speaker |
Demyelinating Disease
Oluwaseun Ogunbona, MD, PhD |
02:35 PM - 02:45 PM PDT | Break |
Break
|
02:45 PM - 03:15 PM PDT | Speaker |
Neurodegenerative Disease
Oluwaseun Ogunbona, MD, PhD |
03:15 PM - 03:45 PM PDT | Speaker |
Neurodevelopmental Disorders
Carrie Mohila, MD, PhD |
03:15 PM - 04:15 PM PDT | Speaker |
Skeletal Muscle and Peripheral Nerve
Carrie Mohila, MD, PhD |
04:15 PM - 04:45 PM PDT | Speaker |
Cerebrovascular Disorders
Ashley Holloman, MD |
04:45 PM - 05:15 PM PDT | Speaker |
Toxic/Metabolic Disorders
Ashley Holloman, MD |
05:15 PM - 05:30 PM PDT | Q&A |
Questions and Answers
Ashley Holloman, MD |
Ashley Holloman, MD | Dr. Holloman has nothing to disclose. |
Oluwaseun Ogunbona, MD, PhD | No disclosure on file |
Carrie Mohila, MD, PhD | Dr. Mohila has stock in Johnson & Johnson. The institution of Dr. Mohila has received research support from NINDS. The institution of Dr. Mohila has received research support from National MS Society. The institution of Dr. Mohila has received research support from Diana Helis Foundation. The institution of Dr. Mohila has received research support from NINDS. |
Hsiang-Chih Lu, MD, PhD | Dr. Lu has nothing to disclose. |